Zhejiang Huahai Pharmaceutical Co., Ltd.

Overview

Zhejiang Huahai Pharmaceutical Co., Ltd. is a leading pharmaceutical company based in China, specializing in the research, development, and production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is dedicated to innovation in therapeutics with a strong focus on quality and compliance.

Core services & business areas

Therapeutic areas

Active pharmaceutical ingredients supplied

Substances Zhejiang Huahai Pharmaceutical Co., Ltd. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Zhejiang Huahai Pharmaceutical Co., Ltd. holds 89 active (100 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• SACUBITRIL SODIUMActive2026-04-30
• SEMAGLUTIDE INTERMEDIATE P29Active2026-03-03
• PERINDOPRIL ARGININEActive2025-07-30
• BRIVARACETAM (PROCESS II)Active2024-10-31
• VORTIOXETINE HYDROBROMIDEActive2024-09-26
• SACUBITRIL VALSARTAN SODIUMActive2024-07-12
• NICARDIPINE HYDROCHLORIDE USPActive2024-01-31
• OSELTAMIVIR PHOSPHATE USPActive2023-12-20
• DAPAGLIFLOZIN PROPANEDIOL (PROCESS II) USPActive2023-11-30
• EDOXABAN TOSYLATE MONOHYDRATEActive2023-10-31
• CARIPRAZINE HYDROCHLORIDEActive2023-09-26
• LEVETIRACETAM, USP (PROCESS VII)Active2022-12-29
• EMPAGLIFLOZIN (PROCESS II)Active2022-12-23
• BRIVARACETAMActive2022-09-26
• RANOLAZINEActive2022-08-25

Showing 15 of 100 Drug Master Files.

FDA compliance signals